
|Articles|April 1, 2010
- Pharmaceutical Executive-04-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - April 2010
HBA Woman of the Year
Advertisement
Articles in this issue
over 15 years ago
Q&A: Geno Germanoover 15 years ago
Woman of the Year: Deirdre Connellyalmost 16 years ago
Managing the Three Drivers of Risk in Drug Developmentalmost 16 years ago
How to Save Your Drug Companyalmost 16 years ago
Science to the Rescuealmost 16 years ago
Twice as NiceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5




